Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells

References

• Xirodimas DP. Novel substrates and functions for the ubiquitin-like molecule NEDD8. Biochem Soc Trans 2008; 36:802-6; PMID:18793140; http://dx.doi.org/10.1042/BST0360802
   PubMed Web of Science ®Google Scholar
• Rabut G, Peter M. Function and regulation of protein neddylation. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep 2008; 9:969-76; PMID:18802447; http://dx.doi.org/10.1038/embor.2008.183
   PubMed Web of Science ®Google Scholar
• Soucy TA, Dick LR, Smith PG, Milhollen MA, Brownell JE. The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy. Genes Cancer 2010; 1:708-16; PMID:21779466; http://dx.doi.org/10.1177/1947601910382898
   PubMedGoogle Scholar
• Duncan K, Schafer G, Vava A, Parker MI, Zerbini LF. Targeting neddylation in cancer therapy. Future Oncol 2012; 8:1461-70; PMID:23148618; http://dx.doi.org/10.2217/fon.12.131
   PubMed Web of Science ®Google Scholar
• Wang M, Medeiros BC, Erba HP, DeAngelo DJ, Giles FJ, Swords RT. Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancer. Expert Opin Ther Targets 2011; 15:253-64; PMID:21219242; http://dx.doi.org/10.1517/14728222.2011.550877
   PubMed Web of Science ®Google Scholar
• Pan ZQ, Kentsis A, Dias DC, Yamoah K, Wu K. Nedd8 on cullin: building an expressway to protein destruction. Oncogene 2004; 23:1985-97; PMID:15021886; http://dx.doi.org/10.1038/sj.onc.1207414
   PubMed Web of Science ®Google Scholar
• Petroski MD, Deshaies RJ. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 2005; 6:9-20; PMID:15688063; http://dx.doi.org/10.1038/nrm1547
   PubMed Web of Science ®Google Scholar
• Deshaies RJ, Joazeiro CA. RING domain E3 ubiquitin ligases. Annu Rev Biochem 2009; 78:399-434; PMID:19489725; http://dx.doi.org/10.1146/annurev.biochem.78.101807.093809
   PubMed Web of Science ®Google Scholar
• Soucy TA, Smith PG, Milhollen MA, Berger AJ, Gavin JM, Adhikari S, Brownell JE, Burke KE, Cardin DP, Critchley S, et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 2009; 458:732-6; PMID:19360080; http://dx.doi.org/10.1038/nature07884
   PubMed Web of Science ®Google Scholar
• Cardozo T, Pagano M. The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol 2004; 5:739-51; PMID:15340381; http://dx.doi.org/10.1038/nrm1471
   PubMed Web of Science ®Google Scholar
• Duda DM, Borg LA, Scott DC, Hunt HW, Hammel M, Schulman BA. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 2008; 134:995-1006; PMID:18805092; http://dx.doi.org/10.1016/j.cell.2008.07.022
   PubMed Web of Science ®Google Scholar
• Saha A, Deshaies RJ. Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation. Mol Cell 2008; 32:21-31; PMID:18851830; http://dx.doi.org/10.1016/j.molcel.2008.08.021
   PubMed Web of Science ®Google Scholar
• Deshaies RJ, Emberley ED, Saha A. Control of cullin-ring ubiquitin ligase activity by nedd8. Subcell Biochem 2010; 54:41-56; PMID:21222272; http://dx.doi.org/10.1007/978-1-4419-6676-6_4
   PubMedGoogle Scholar
• Jia L, Sun Y. SCF E3 ubiquitin ligases as anticancer targets. Curr Cancer Drug Targets 2011; 11:347-56; PMID:21247385; http://dx.doi.org/10.2174/156800911794519734
   PubMed Web of Science ®Google Scholar
• Jia L, Li H, Sun Y. Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression. Neoplasia 2011; 13:561-9; PMID:21677879
   PubMed Web of Science ®Google Scholar
• Lin JJ, Milhollen MA, Smith PG, Narayanan U, Dutta A. NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells. Cancer Res 2010; 70:10310-20; PMID:21159650; http://dx.doi.org/10.1158/0008-5472.CAN-10-2062
   PubMed Web of Science ®Google Scholar
• Luo Z, Yu G, Lee HW, Li L, Wang L, Yang D, Pan Y, Ding C, Qian J, Wu L, et al. The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth. Cancer Res 2012; 72:3360-71; PMID:22562464; http://dx.doi.org/10.1158/0008-5472.CAN-12-0388
   PubMed Web of Science ®Google Scholar
• Mackintosh C, Garcia-Dominguez DJ, Ordonez JL, Ginel-Picardo A, Smith PG, Sacristan MP, de Alava E. WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells. Oncogene 2013; 32:1441-51; PMID:22641220; http://dx.doi.org/10.1038/onc.2012.153
   PubMed Web of Science ®Google Scholar
• Milhollen MA, Narayanan U, Soucy TA, Veiby PO, Smith PG, Amidon B. Inhibition of NEDD8-activating enzyme induces rereplication and apoptosis in human tumor cells consistent with deregulating CDT1 turnover. Cancer Res 2011; 71:3042-51; PMID:21487042; http://dx.doi.org/10.1158/0008-5472.CAN-10-2122
   PubMed Web of Science ®Google Scholar
• Milhollen MA, Traore T, Adams-Duffy J, Thomas MP, Berger AJ, Dang L, Dick LR, Garnsey JJ, Koenig E, Langston SP, et al. MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma. Blood 2010; 116:1515-23; PMID:20525923; http://dx.doi.org/10.1182/blood-2010-03-272567
   PubMed Web of Science ®Google Scholar
• Swords RT, Kelly KR, Smith PG, Garnsey JJ, Mahalingam D, Medina E, Oberheu K, Padmanabhan S, O'Dwyer M, Nawrocki ST, et al. Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia. Blood 2010; 115:3796-800; PMID:20203261; http://dx.doi.org/10.1182/blood-2009-11-254862
   PubMed Web of Science ®Google Scholar
• Luo Z, Pan Y, Jeong LS, Liu J, Jia L. Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells. Autophagy 2012; 8:1677-9; PMID:22874562; http://dx.doi.org/10.4161/auto.21484
   PubMed Web of Science ®Google Scholar
• Zhao Y, Xiong X, Jia L, Sun Y. Targeting Cullin-RING ligases by MLN4924 induces autophagy via modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis. Cell Death Dis 2012; 3:e386; PMID:22951983; http://dx.doi.org/10.1038/cddis.2012.125
   PubMed Web of Science ®Google Scholar
• Yao WT, Wu JF, Yu GY, Wang R, Wang K, Li LH, Chen P, Jiang YN, Cheng H, Lee HW, et al. Suppression of tumor angiogenesis by targeting the protein neddylation pathway. Cell Death Dis 2014; 5:e1059; PMID:24525735; http://dx.doi.org/10.1038/cddis.2014.21
   PubMedGoogle Scholar
• Nawrocki ST, Griffin P, Kelly KR, Carew JS. MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy. Expert Opin Investig Drugs 2012; 21:1563-73; PMID:22799561; http://dx.doi.org/10.1517/13543784.2012.707192
   PubMed Web of Science ®Google Scholar
• Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet 2012; 380:848-57; PMID:22835603; http://dx.doi.org/10.1016/S0140-6736(12)60605-9
   PubMed Web of Science ®Google Scholar
• Dengler MA, Weilbacher A, Gutekunst M, Staiger AM, Vohringer MC, Horn H, Ott G, Aulitzky WE, van der Kuip H. Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles' heel in mantle cell lymphoma. Cell Death Dis 2014; 5:e1013; PMID:24457957; http://dx.doi.org/10.1038/cddis.2013.552
   PubMed Web of Science ®Google Scholar
• Godbersen JC, Humphries LA, Danilova OV, Kebbekus PE, Brown JR, Eastman A, Danilov AV. The Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF-kappaB Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells. Clin Cancer Res 2014; 20:1576-89; PMID:24634471; http://dx.doi.org/10.1158/1078-0432.CCR-13-0987
   PubMed Web of Science ®Google Scholar
• Sundstrom C, Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976; 17:565-77; PMID:178611; http://dx.doi.org/10.1002/ijc.2910170504
   PubMed Web of Science ®Google Scholar
• Sarcar B, Kahali S, Prabhu AH, Shumway SD, Xu Y, Demuth T, Chinnaiyan P. Targeting radiation-induced G(2) checkpoint activation with the Wee-1 inhibitor MK-1775 in glioblastoma cell lines. Mol Cancer Ther 2011; 10:2405-14; PMID:21992793; http://dx.doi.org/10.1158/1535-7163.MCT-11-0469
   PubMed Web of Science ®Google Scholar
• Fischle W, Tseng BS, Dormann HL, Ueberheide BM, Garcia BA, Shabanowitz J, Hunt DF, Funabiki H, Allis CD. Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature 2005; 438:1116-22; PMID:16222246; http://dx.doi.org/10.1038/nature04219
   PubMed Web of Science ®Google Scholar
• Yang D, Li L, Liu H, Wu L, Luo Z, Li H, Zheng S, Gao H, Chu Y, Sun Y, et al. Induction of autophagy and senescence by knockdown of ROC1 E3 ubiquitin ligase to suppress the growth of liver cancer cells. Cell Death Differ 2013; 20:235-47; PMID:22935614; http://dx.doi.org/10.1038/cdd.2012.113
   PubMed Web of Science ®Google Scholar
• Lin HK, Chen Z, Wang G, Nardella C, Lee SW, Chan CH, Yang WL, Wang J, Egia A, Nakayama KI, et al. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature 2010; 464:374-9; PMID:20237562; http://dx.doi.org/10.1038/nature08815
   PubMed Web of Science ®Google Scholar
• Hoffman RM, Jacobsen SJ. Reversible growth arrest in simian virus 40-transformed human fibroblasts. Proc Natl Acad Sci U S A 1980; 77:7306-10; PMID:6261250; http://dx.doi.org/10.1073/pnas.77.12.7306
   PubMed Web of Science ®Google Scholar
• Stern PH, Hoffman RM. Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. J Natl Cancer Inst 1986; 76:629-39; PMID:3457200
   PubMed Web of Science ®Google Scholar
• Sorenson CM, Barry MA, Eastman A. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst 1990; 82:749-55; PMID:1691303; http://dx.doi.org/10.1093/jnci/82.9.749
   PubMed Web of Science ®Google Scholar
• Tsao YP, D'Arpa P, Liu LF. The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B. Cancer Res 1992; 52:1823-9; PMID:1312900
   PubMed Web of Science ®Google Scholar
• Gao Q, Yu GY, Shi JY, Li LH, Zhang WJ, Wang ZC, Yang LX, Duan M, Zhao H, Wang XY, et al. Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target. Oncotarget 2014; 5:7820-32; PMID:25229838
   PubMed Web of Science ®Google Scholar
• Wei D, Li H, Yu J, Sebolt JT, Zhao L, Lawrence TS, Smith PG, Morgan MA, Sun Y. Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor. Cancer Res 2012; 72:282-93; PMID:22072567; http://dx.doi.org/10.1158/0008-5472.CAN-11-2866
   PubMed Web of Science ®Google Scholar
• Li L, Wang M, Yu G, Chen P, Li H, Wei D, Zhu J, Xie L, Jia H, Shi J, et al. Overactivated neddylation pathway as a therapeutic target in lung cancer. J Natl Cancer Inst 2014; 106:dju083; PMID:24853380
   PubMed Web of Science ®Google Scholar
• Wang X, Li L, Liang Y, Li C, Zhao H, Ye D, Sun M, Jeong LS, Feng Y, Fu S, et al. Targeting the neddylation pathway to suppress the growth of prostate cancer cells: therapeutic implication for the men's cancer. Biomed Res Int 2014; 2014:974309; PMID:25093192
   PubMedGoogle Scholar
• Nawrocki ST, Kelly KR, Smith PG, Espitia CM, Possemato A, Beausoleil SA, Milhollen M, Blakemore S, Thomas M, Berger A, et al. Disrupting Protein NEDDylation with MLN4924 Is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer. Clin Cancer Res 2013; 19:3577-90; PMID:23633453; http://dx.doi.org/10.1158/1078-0432.CCR-12-3212
   PubMed Web of Science ®Google Scholar
• Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, Lowe SW. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 2002; 109:335-46; PMID:12015983; http://dx.doi.org/10.1016/S0092-8674(02)00734-1
   PubMed Web of Science ®Google Scholar
• Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729-40; PMID:17667954; http://dx.doi.org/10.1038/nrm2233
   PubMed Web of Science ®Google Scholar
• Deng Y, Chan SS, Chang S. Telomere dysfunction and tumour suppression: the senescence connection. Nat Rev Cancer 2008; 8:450-8; PMID:18500246; http://dx.doi.org/10.1038/nrc2393
   PubMed Web of Science ®Google Scholar
• Itahana K, Campisi J, Dimri GP. Mechanisms of cellular senescence in human and mouse cells. Biogerontology 2004; 5:1-10; PMID:15138376; http://dx.doi.org/10.1023/B:BGEN.0000017682.96395.10
   PubMed Web of Science ®Google Scholar
• Duthu A, Debuire B, Romano J, Ehrhart JC, Fiscella M, May E, Appella E, May P. p53 mutations in Raji cells: characterization and localization relative to other Burkitt's lymphomas. Oncogene 1992; 7:2161-7; PMID:1437144
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Toyoshima H, Sakai R, Miyagawa K, Hagiwara K, Ishikawa F, Takaku F, Yazaki Y, Hirai H. Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood 1992; 79:2378-83; PMID:1571549
   PubMed Web of Science ®Google Scholar
• Chim CS, Wong AS, Kwong YL. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias. Ann Hematol 2003; 82:738-42; PMID:14513284; http://dx.doi.org/10.1007/s00277-003-0744-8
   PubMed Web of Science ®Google Scholar
• Klangby U, Okan I, Magnusson KP, Wendland M, Lind P, Wiman KG. p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma. Blood 1998; 91:1680-7; PMID:9473234
   PubMed Web of Science ®Google Scholar
• Miftakhova R, Sandberg T, Hedblom A, Nevzorova T, Persson JL, Bredberg A. DNA methylation in ATRA-treated leukemia cell lines lacking a PML-RAR chromosome translocation. Anticancer Res 2012; 32:4715-22; PMID:23155234
   PubMed Web of Science ®Google Scholar
• Lee HW, Nam SK, Choi WJ, Kim HO, Jeong LS. Stereoselective synthesis of MLN4924, an inhibitor of NEDD8-activating enzyme. J Org Chem 2011; 76:3557-61; PMID:21417215; http://dx.doi.org/10.1021/jo2001897
   PubMed Web of Science ®Google Scholar
• Jia L, Soengas MS, Sun Y. ROC1/RBX1 E3 ubiquitin ligase silencing suppresses tumor cell growth via sequential induction of G2-M arrest, apoptosis, and senescence. Cancer Res 2009; 69:4974-82; PMID:19509229; http://dx.doi.org/10.1158/0008-5472.CAN-08-4671
   PubMed Web of Science ®Google Scholar
• Jia L, Yang J, Hao X, Zheng M, He H, Xiong X, Xu L, Sun Y. Validation of SAG/RBX2/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target. Clin Cancer Res 2010; 16:814-24; PMID:20103673; http://dx.doi.org/10.1158/1078-0432.CCR-09-1592
   PubMed Web of Science ®Google Scholar
• Li L, Liu B, Dong T, Lee HW, Yu J, Zheng Y, Gao H, Zhang Y, Chu Y, Liu G, et al. Neddylation pathway regulates the proliferation and survival of macrophages. Biochem Biophys Res Commun 2013; 432:494-8; PMID:23416079; http://dx.doi.org/10.1016/j.bbrc.2013.02.028
   PubMed Web of Science ®Google Scholar
• Itahana K, Campisi J, Dimri GP. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol 2007; 371:21-31; PMID:17634571; http://dx.doi.org/10.1007/978-1-59745-361-5_3
   PubMedGoogle Scholar
• Lubelska K, Milczarek M, Modzelewska K, Krzyszton-Russjan J, Fronczyk K, Wiktorska K. Interactions between drugs and sulforaphane modulate the drug metabolism enzymatic system. Pharmacol Rep 2012; 64:1243-52; PMID:23238480; http://dx.doi.org/10.1016/S1734-1140(12)70920-9
   PubMed Web of Science ®Google Scholar
• Cerda SR, Mustafi R, Little H, Cohen G, Khare S, Moore C, Majumder P, Bissonnette M. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators. Oncogene 2006; 25:3123-38; PMID:16434969; http://dx.doi.org/10.1038/sj.onc.1209360
   PubMed Web of Science ®Google Scholar
• Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH, Hur K, Yoo MW, Lee HJ, Yang HK, et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 2009; 37:1672-81; PMID:19153141; http://dx.doi.org/10.1093/nar/gkp002
   PubMed Web of Science ®Google Scholar
• Shi W, Li X, Hou X, Peng H, Jiang Q, Shi M, Ji Y, Liu X, Liu J. Differential apoptosis gene expressions of rhabdomyosarcoma cells in response to enterovirus 71 infection. BMC Infect Dis 2012; 12:327; PMID:23191987; http://dx.doi.org/10.1186/1471-2334-12-327
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar